gsthr logo
Quick links to detailed datasheets for United States of America at gsthr.org

Smoking in United States of America

In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).

Read articles from United States of America

November 16, 2021 by None

Tobacco lawsuits could upend Biden's plan for historic menthol ban

The Food and Drug Administration’s renewed push to regulate e-cigarettes could interfere with the Biden administration’s plans to ban menthol-flavored tobacco products, a long-sought goal of public health groups.

On Nov. 18, the agency will square off in a federal district court with anti-tobacco groups that say it has unreasonably delayed action to limit the minty flavor in tobacco products, despite ample evidence of menthol’s toll on public health.

November 12, 2021 by thehill.com

Up in smoke: Will Biden let a patent fight eliminate an alternative to cigarettes?

President Biden's
Build Back Better agenda depends a lot on smokers and their compulsive habit. Smoking generates tax revenue — lots of it. Part of the theory is that high taxes, restrictions on advertising, research on the deleterious health effects of smoking, and the cultural stigma surrounding smoking will wean Americans off tobacco, but too much success on that front also will dry up big tax revenue. As part of the package of funding measures, the administration had sought to raise federal taxes on cigarettes by 50 percent and on other tobacco products like dipping tobacco by 1,600 percent. [...]

November 12, 2021 by marketwatch.com

House Democrats want vaping tax in social-spending plan, sparking fears people will go back to cigarettes

House Democrats are poised to vote on imposing a new federal excise tax on e-cigarettes—but without a tax increase on traditional cigarettes—leading some public-health experts to warn that the provision could push vapers back to cigarette smoking.

 

The House bill includes a measure intended to tax vaping products on par with the existing federal cigarette tax rate of $1.01 per pack. It would raise about $9 billion over a decade. The nicotine tax would apply to e-cigarettes, vaping liquids and oral nicotine pouches. It wouldn’t apply to nicotine gums, patches or other smoking-cessation aids approved as medical products by the Food and Drug Administration.

November 04, 2021 by filtermag.org

FDA Memos Reveal Its “Fatal Flaw” Rejection Plan for Flavored Vapes

There’s an ongoing theory about the Food and Drug Administration (FDA) within the vaping community: The agency did not anticipate the onslaught of 6 million-plus premarket tobacco product applications (PMTAs) it received by a September 2020 deadline, and had to devise some way to try to sort through them all by the following year. It would be no easy feat, but the bar for authorization would be set incredibly high—and that, in the FDA’s view, would help.

November 03, 2021 by nationalreview.com

The FDA’s Overdue Approval of E-Cigarettes

The Food and Drug Administration is facing backlash from anti-vaping members of Congress and other public-health campaigners for officially authorizing an e-cigarette as “appropriate for the protection of public health.”

The FDA’s decision to approve the Vuse Solo e-cigarette last month is a historic one: It marks the first time that America’s leading public-health agency officially recognized the potential of e-cigarettes to help smokers quit. “The manufacturer’s data demonstrates its tobacco-flavored products could benefit addicted adult smokers who switch to these products — either completely or with a significant reduction in cigarette consumption,” [...]

November 03, 2021 by cincinnati.com

Opinion: FDA must stop marketing of vaping products to minors

Building strong families and communities is the key to unlocking the potential of our next generation. Unfortunately, Kentucky leads the nation in too many cancer statistics – including the rate of new lung cancer diagnoses. These chronic health issues prevent our youth from getting the right start.

Everyone, from policymakers to advocates to educators to parents, needs to be involved in the effort to keep vaping products like Juul away from our children. That’s why I’m so alarmed the Food and Drug Administration (FDA) continues to drag its feet in regulating or outright banning flavored e-cigarette and vaping devices.

October 28, 2021 by reuters.com

Texas company can keep selling flavored e-cigs, 5th Circuit rules

Triton Distribution can continue selling its flavored e-cigarettes, a federal appeals court has ruled, despite the U.S. Food and Drug Administration's decision to the contrary.

In a unanimous opinion on Tuesday, the 5th U.S. Circuit Court of Appeals said that when the FDA last month denied the Richardson, Texas-based company's application to sell its products, the agency did not give adequate consideration to Triton's marketing plan to reduce the products' appeal to youth.

October 27, 2021 by denverpost.com

Push to ban sale of flavored tobacco, vape juices in Denver sparks intense debate

A push to outlaw the sale of flavored smoking products in Denver has drawn Big Tobacco, mom-and-pop vape shops, hookah lounges, health care providers and social justice advocates into a fight over public health, business rights and the freedom of choice.

The proposal under consideration by the Denver City Council is becoming one of the most intensely debated issues in City Hall in recent years, with public health advocates saying a ban would help end the teen vaping crisis while the opposition argues the city would be going too far in restricting access to products that adults have a right to use.

October 26, 2021 by filtermag.org

FDA Puts A Second Vape Company Back Under Review

On October 22, the Food and Drug Administration (FDA) put Fumizer’s flavored vaping products back under review—rescinding the denial it had issued in September. [...]

In early September, the FDA issued a marketing denial order (MDO) for Fumizer’s flavored vaping products. The company, like all others in the United States, had until September 2020 to file a premarket tobacco product application (PMTA) in order for its vapes and e-liquids to remain on the marketplace. The FDA, in turn, had until September 2021 to look over the PMTAs, which companies had to submit for every single product they wanted to keep selling.

October 22, 2021 by filtermag.org

Backlash Against the FDA Grows as Vape Company Ramps Up Legal Fight

On October 20, My Vape Order (MVO) petitioned a federal court of appeals for “an emergency motion for a stay pending a review and for expedited consideration” on the company’s vapor products that have been removed from the market.

In early September, the Food and Drug Administration (FDA) had issued a marketing denial order for MVO’s products. Like all other vape companies in the United States, MVO had until September 2020 to file premarket tobacco product applications (PMTAs) to be able to keep selling its vapes and e-liquids; the FDA, in turn, had until September 2021 to review the PMTAs.